Amgen
AMGN
Performance
About Amgen
Amgen is a global biotechnology company dedicated to discovering, developing, manufacturing and delivering innovative human therapeutics for serious illnesses. The company operates worldwide across multiple therapy areas, including oncology, cardiovascular/metabolic, bone health and inflammation, and emphasizes science-driven approaches to improve patient outcomes. Amgen emphasizes research and development, manufacturing excellence, and responsible innovation as core to its mission. Headquartered in the United States, it maintains a broad global presence and engages in clinical trials, manufacturing, and patient safety initiatives around the world.
Recent News
WHCD Shooting, DOJ Ends Powell Probe, Musk Vs. Altman and More in Morning Squawk
#JPM26: Day 2 at the JP Morgan Healthcare Conference
Amgen Ends Partnership with Kyowa Kirin on Immunology Drug, Despite Phase 3 Wins
Biogen Seals $5.3 B Deal for Apellis, Adds Two Blockbuster Drugs
AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules
S&P 500 Hits New High on Apple Earnings: Stock Market Today
FDA Launches Real-Time Clinical Trials Pilot to Cut Drug Development Timelines
AbbVie Sinks Talons Into KRAS with Right to Buy Kestrel for up to $1.45B
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-Cell Engager Therapy
CDER Proposes to Withdraw Approval of TAVNEOS
Omeros Corp (OMER) Q1 2026 Earnings Call Transcript
GSK Functionally Cures Hepatitis B, Lilly's $3.8B Vaccine Pivot, and Base Editing Holds for 18 Months – This Week in Biotech #102
FDA Grants Priority Review to Ifinatamab Deruxtecan for Treated Small Cell Lung Cancer
BBOT Secures FDA Fast Track for Pan-KRAS Inhibitor BBO-11818 in KRAS‑Mutant Pancreatic Cancer
‘Research Here Is World Class’: Son of Steve Jobs Looks to Invest in UK Cancer Care
The Next Generation of GLP-1 Drugs: And How They’ll Reshape Food and Beverage Again
Amgen Launches Late-Stage Obesity Trial in Patients Who Switch From Rival Drugs
Pharma and Biotech Layoffs 2026 Watch
Dow Jones Slides 322 Points as 30‑Year Treasury Yield Hits 19‑Year High
Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge
BBOT Shakes up Leadership as RAS Competitors Get More Visibility
Senju Launches First-in-Class Dry Eye Disease Drug in Japan
Amgen’s Rare Disease Drug Tavneos Tied to 20 Deaths in Japan
Amgen Adds AML Candidate in Deal for U.K.-based Dark Blue: Deals Report
Tech Stocks Surge as Healthcare Faces Setbacks
Small Cell Lung Cancer Research Moves Toward a More Precision-Driven Era
Amgen’s Lung Cancer Drug Tarlatamab Wins China Approval
AAN 2026: Head-to-Head Trial Shows Superiority of Qulipta for Migraine Prevention
Well-Known Genus, Novel Method: A Post-Amgen Framework for Written Description & Enablement
Quantinuum Targets $20 B Valuation in 2026 Quantum Computing IPO
29 Exciting Companies Hiring Professionals in 2026
Amgen Files Update to Tavneos Label as FDA Escalates Push to Withdraw
The Company that Built TikTok’s Algorithm Is Now Designing Drugs for Diseases Pharma Called Undruggable
Amgen Names Former Exec Thomas Dittrich CFO as Peter Griffith Retires
Trump’s New Drug Advertising Proposals Fall Short on Public Health and the Constitution
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus
Linvoseltamab Data ‘Encouraging’ in Relapsed AL Amyloidosis
STAT+: Boehringer’s Obesity Drug Shows 16.6% Weight Loss; More Data Needed
Strategy Pivot Hits GoodRx
Lilly Lands Vaccine Trifecta with 3 New Biotech Buys Valued at up to $3.8B
Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal
Amgen Adds $300M to Puerto Rico Budget; Novartis to Exit Oral Drug Factory in Germany
Ceasefire Extension, Best Buy's New CEO, Amazon's GLP-1 Push and More in Morning Squawk
Honeywell International Inc (HON) Q1 2026 Earnings Call Transcript
Amgen Posts $5.6 B Q1 Revenue, Raises 2026 Guidance Amid Pipeline Gains
Proteasomes: A Novel Approach to Target the Immune System
Korea’s Ildong Promotes Chae Joon Lee to Co-CEO
Tenpoint Wins FDA Nod for Combination Presbyopia Eye Drop
Nine Biotech Companies that Could Revolutionize Obesity Treatments